Hong Kong stock market fluctuates | Meirui Biological-B(02493.HK) surged over 6% in the morning, Injection 6MW5311 clinical trial application receives FDA approval.

According to the Securities Times app, Miwei Bio-B (02493.HK) rose more than 6% in the morning, up 6.22% as of the time of publication, at 26.66 Hong Kong dollars, with a transaction volume of 12.56 million Hong Kong dollars.